NCT06170216 2024-02-23
Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)
Fudan University
Unknown
Clinical Trials
215 trialsNCT05865678 2024-02-21
SKETCh
The Christie NHS Foundation Trust
Unknown
NCT06224309 2024-02-09
Preliminary Assessment of [18F]BL40 in PET/CT Scans
British Columbia Cancer Agency
Unknown
NCT06202885 2024-01-12
CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy
Seoul St. Mary's Hospital
Unknown
NCT05078840 2024-01-09
PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors
Grupo Argentino de Tratamiento de la Leucemia Aguda
Unknown
NCT05728801 2023-12-12
Decoding the Cognitive Trajectory of Hong Kong SuperAgers: a Longitudinal Follow-up Study
Chinese University of Hong Kong
Unknown
NCT05846672 2023-12-12
Turkish Cultural Adaptation, Validity and Reliability of the "Gait Outcomes Assessment List"
Istanbul University - Cerrahpasa
Unknown
NCT05025150 2023-11-28
Point-of-Care Ultrasound for Pediatric Thoracic Trauma: A Multi-Institutional Trial
Sutter Health
Unknown
NCT05803395 2023-11-28
Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown
NCT05235633 2023-11-24
ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin Lymphoma
Technical University of Munich
Unknown
NCT04870853 2023-11-14
Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy
M.D. Anderson Cancer Center
Unknown
NCT06110182 2023-10-31
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Central Hospital, Nancy, France
Unknown
NCT06106776 2023-10-30
CARdio-Tox
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown
NCT06107478 2023-10-30
MASSAYA
Centre Leon Berard
Unknown
NCT05495828 2023-10-26
Orelabrutinib Therapy in Patients With r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase Inhibitors
Peking University People's Hospital
Unknown
NCT06092203 2023-10-23
Elattar
Mansoura University
Unknown
NCT06049381 2023-09-22
Tumor Microenvironment Mechanism of LY007 for r/r B-NHL and the Exploration of Novel CAR-T Translational Research
Ruijin Hospital
Unknown
NCT04187118 2023-09-21
QUALIPSO-L
University Hospital, Toulouse
Unknown
NCT04985214 2023-09-21
EVEREST
University Hospital, Toulouse
Unknown
NCT06018324 2023-08-30
CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
Diabeter Nederland BV
Unknown
NCT06015464 2023-08-29
An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05977387 2023-08-04
PeKiT
Imagine Institute
Unknown
NCT05967975 2023-08-01
Elastography and Treatment of Lymphoma
Assiut University
Unknown
NCT05943093 2023-07-13
H19 in Acute Lymphoblastic Leukemia.
Assiut University
Unknown
NCT05923879 2023-06-28
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
Ruijin Hospital
Unknown
NCT04554511 2023-06-18
Prognostic Nomogram of Extranodal NK/T-cell Lymphoma
Sun Yat-sen University
Unknown
NCT05907447 2023-06-18
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
Ruijin Hospital
Unknown
NCT05218772 2023-06-08
SENIORHEMO
Assistance Publique Hopitaux De Marseille
Unknown
NCT05888701 2023-06-05
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
University of Milano Bicocca
Unknown
NCT05883709 2023-06-01
A Real-world Study of Tafasitamab in Combination With Lenalidomide in Patients withR/R DLBCL
Ruijin Hospital
Unknown
NCT05639673 2023-05-26
Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
Rigshospitalet, Denmark
Unknown
NCT05303155 2023-05-19
The Association of Gut Microbiota With COVID 19 Infection in Children
Hallym University Kangnam Sacred Heart Hospital
Unknown
NCT05855460 2023-05-11
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
Cairo University
Unknown
NCT05852028 2023-05-10
A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
Ruijin Hospital
Unknown
NCT05793463 2023-03-31
Anti-mullerian Hormone in Acute Lymphoblastic Leukemia
IRCCS Burlo Garofolo
Unknown
NCT05004961 2023-03-03
The Performance of Multi-tracer Multimodality PET in Lymphoma
Peking University Cancer Hospital & Institute
Unknown
NCT05390632 2023-03-03
Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
Peking University Cancer Hospital & Institute
Unknown
NCT05731375 2023-02-16
MUSCLE
UMC Utrecht
Unknown
NCT03797170 2023-02-08
Design of New Personalized Therapeutic Approaches for Diffuse Large B-cell Lymphoma
University of Bologna
Unknown
NCT04092348 2023-02-08
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia
Assiut University
Unknown
NCT05693519 2023-01-23
GICCA
Leiden University Medical Center
Unknown
NCT05680038 2023-01-11
Penpulimab in Maintenance Therapy in Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Unknown
NCT05663983 2022-12-23
Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients
Campus Bio-Medico University
Unknown
NCT05664230 2022-12-23
Leucosteo
Assistance Publique - Hôpitaux de Paris
Unknown
NCT05628558 2022-11-28
GIDEMHA
Groupe Maladies hémorragiques de Bretagne
Unknown
NCT05254821 2022-11-14
Cell-free Tumor DNA as Minimal Residual Disease in Hodgkin Lymphoma Patients
Federico II University
Unknown
NCT04677309 2022-11-01
THORUS
Hospital General Universitario de Valencia
Unknown
NCT05565898 2022-11-01
PET/CT Vs Bone Marrow Biopsy in Exclusion of Bone Marrow Infiltration for Initial Staging of Lymphoma
Assiut University
Unknown
NCT05600959 2022-11-01
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH
Beijing Friendship Hospital
Unknown
NCT03318770 2022-10-12
Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto
Unknown